home / stock / aveo / aveo quote
Last: | $15 |
---|---|
Change Percent: | 0.03% |
Open: | $14.995 |
Close: | $15 |
High: | $15 |
Low: | $14.99 |
Volume: | 247,877 |
Last Trade Date Time: | 01/19/2023 10:19:21 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$15 | $14.995 | $15 | $15 | $14.99 | 247,877 | 01-19-2023 |
$15 | $14.99 | $15 | $15 | $14.99 | 1,255,220 | 01-18-2023 |
$14.98 | $14.98 | $14.98 | $14.99 | $14.98 | 373,860 | 01-17-2023 |
$14.98 | $14.98 | $14.98 | $14.99 | $14.98 | 243,695 | 01-16-2023 |
$14.98 | $14.98 | $14.98 | $14.99 | $14.98 | 243,695 | 01-13-2023 |
$14.97 | $14.97 | $14.97 | $14.99 | $14.97 | 621,905 | 01-12-2023 |
$14.94 | $14.93 | $14.94 | $14.95 | $14.93 | 276,556 | 01-11-2023 |
$14.93 | $14.95 | $14.93 | $14.95 | $14.93 | 514,125 | 01-10-2023 |
$14.94 | $14.94 | $14.94 | $14.95 | $14.91 | 577,427 | 01-09-2023 |
$14.93 | $14.95 | $14.93 | $14.95 | $14.93 | 799,209 | 01-06-2023 |
$14.96 | $14.94 | $14.96 | $14.965 | $14.93 | 865,861 | 01-05-2023 |
$14.94 | $14.96 | $14.94 | $14.96 | $14.94 | 629,087 | 01-04-2023 |
$14.96 | $14.93 | $14.96 | $14.97 | $14.93 | 813,078 | 01-03-2023 |
$14.95 | $14.94 | $14.95 | $14.97 | $14.91 | 662,151 | 01-02-2023 |
$14.95 | $14.94 | $14.95 | $14.97 | $14.91 | 662,151 | 12-30-2022 |
$14.94 | $14.94 | $14.94 | $14.97 | $14.93 | 242,061 | 12-29-2022 |
$14.94 | $14.97 | $14.94 | $14.98 | $14.93 | 293,727 | 12-28-2022 |
$14.97 | $14.94 | $14.97 | $14.97 | $14.94 | 203,034 | 12-27-2022 |
$14.93 | $14.92 | $14.93 | $14.94 | $14.92 | 292,792 | 12-26-2022 |
$14.93 | $14.92 | $14.93 | $14.94 | $14.92 | 292,792 | 12-23-2022 |
News, Short Squeeze, Breakout and More Instantly...
AVEO Pharmaceuticals Inc. Company Name:
AVEO Stock Symbol:
NASDAQ Market:
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation ...
SEOUL, South Korea, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LG Chem, Ltd. (“LG Chem”) (KOSPI: 051910) today announced that it has completed its previously announced acquisition of AVEO Oncology (“AVEO”), a commercial stage, oncology-focused biopharmaceutical company committe...
BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders ...